Ajay Kumar Dhadha - 05 Mar 2025 Form 4 Insider Report for Raphael Pharmaceutical Inc. (RAPH)

Role: Director
Signature: /s/ Ajay Kumar Dhadha
Issuer symbol: RAPH
Transactions as of: 05 Mar 2025
Net transactions value: $0
Form type: 4
Filing time: 06 Mar 2025, 16:05:52 UTC
Previous filing: 13 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RAPH	Common Stock	Award	$0	+350,000	+20996%	$0.000000	351,667	05 Mar 2025	Direct	F1
holding	RAPH	Common Stock						403,153	05 Mar 2025	By Shanti Gems International Investments Ltd.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RAPH	Warrant to purchase Common Stock	Award	$0	+250,000		$0.000000	250,000	05 Mar 2025	Common Stock	250,000	$1.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	350,000 shares of Common Stock and 250,000 Warrants to purchase shares of Common Stock of the issuer were received as compensation for the reporting person's service as a director and chairman of the Issuer's board of directors pursuant to a service agreement by and between the issuer and the reporting person, entered on March 5, 2025. The Warrants are exercisable immediately and will expire on December 31, 2026.

Content

350,000 shares of Common Stock and 250,000 Warrants to purchase shares of Common Stock of the issuer were received as compensation for the reporting person's service as a director and chairman of the Issuer's board of directors pursuant to a service agreement by and between the issuer and the reporting person, entered on March 5, 2025. The Warrants are exercisable immediately and will expire on December 31, 2026.